Pan Z J, Anderson C J, Stafford H A
Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
J Clin Invest. 1998 Jul 1;102(1):215-22. doi: 10.1172/JCI1969.
A subset of SLE patients has serologically detectable autoantibodies to the ribosomal P proteins (anti-P). We reported the discovery of covert anti-P antibodies and their masking IgG-inhibitory antibodies in the sera of healthy adults. The aim of this study was to determine if these IgG-inhibitory antibodies are anti-idiotypic antibodies (anti-Ids). IgG and IgG-depleted fractions of plasma from two healthy adults were assayed for inhibition of anti-P F(ab')2 binding to the ribosomal P proteins in immunoblot. Anti-P antibody activity was completely inhibited by plasma IgG, whereas there was no inhibition by IgG-depleted plasma. IgG-inhibitory antibodies recognized a cross-reactive epitope among anti-P from different SLE patients. Plasma IgG from one healthy adult was depleted of pepsin agglutinators and generic anti-F(ab')2 antibodies by adsorption with an affinity column prepared with normal IgG F(ab')2. Unretained IgG bound exclusively to anti-P F(ab')2 in ELISA. Using four affinity columns, we isolated IgG anti-Ids to anti-P antibodies from four healthy adults. These purified anti-Ids bound to anti-P F(ab')2 from a healthy adult and SLE patients. They did not bind to F(ab')2 fragments prepared from normal IgG or anti-dsDNA. Ribosomal antigens blocked this anti-Id-Id interaction. Purified anti-Ids inhibited the binding of anti-P F(ab')2 from patients to ribosomal P proteins. SLE patients without overt anti-P antibodies also possessed IgG anti-Ids to anti-P antibodies. We conclude that IgG-inhibitory antibodies are anti-Ids to anti-P antibodies, and are directed to public idiotopes on anti-P antibodies. These anti-Ids may be part of an Id network that regulates anti-P antibody expression, and perhaps pathogenicity.
一部分系统性红斑狼疮(SLE)患者血清中可检测到针对核糖体P蛋白的自身抗体(抗P抗体)。我们报道了在健康成年人血清中发现隐匿性抗P抗体及其掩盖性IgG抑制抗体。本研究的目的是确定这些IgG抑制抗体是否为抗独特型抗体(抗Id)。对两名健康成年人血浆中的IgG和去除IgG的组分进行检测,以观察其在免疫印迹中对抗P F(ab')2与核糖体P蛋白结合的抑制作用。血浆IgG可完全抑制抗P抗体活性,而去除IgG的血浆则无抑制作用。IgG抑制抗体识别不同SLE患者抗P抗体中的交叉反应表位。用正常IgG F(ab')2制备的亲和柱吸附一名健康成年人血浆中的胃蛋白酶凝集素和通用抗F(ab')2抗体。未保留的IgG在酶联免疫吸附测定(ELISA)中仅与抗P F(ab')2结合。使用四根亲和柱,我们从四名健康成年人中分离出抗P抗体的IgG抗Id。这些纯化的抗Id与一名健康成年人及SLE患者的抗P F(ab')2结合。它们不与正常IgG或抗双链DNA(anti-dsDNA)制备的F(ab')2片段结合。核糖体抗原可阻断这种抗Id-Id相互作用。纯化的抗Id可抑制患者抗P F(ab')2与核糖体P蛋白的结合。无明显抗P抗体的SLE患者也拥有抗P抗体的IgG抗Id。我们得出结论,IgG抑制抗体是抗P抗体的抗Id,且针对抗P抗体上的公共独特型表位。这些抗Id可能是调节抗P抗体表达乃至致病性的独特型网络的一部分。